Strong Financial Performance Amid Industry Downturn
MCG delivered a better-than-forecast core operating income of JPY 183.9 billion, and a positive cash flow of JPY 165.7 million, despite the prolonged chemical industry downturn.
Cost Reductions Surpassed Annual Targets
Achieved JPY 82 billion in cost reductions, exceeding the full-year target of JPY 80 billion, contributing to securing profits.
Industrial Gases and Healthcare Performance
Industrial gases saw a sales increase of 6% and profits up by 45%. Healthcare sales rose 6% with a 177% profit increase due to RADICAVA sales in the U.S.